Crystalline, anhydrous forms of oxymorphone hydrochloride

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9440986
APP PUB NO 20150148368A1
SERIAL NO

14613421

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Crystalline, anhydrous hydrochloride salts of 4,5α-epoxy-3,14-dihydroxy-17-methylmorphinan-6-one (oxymorphone) are disclosed and three polymorphic forms of these salts are reported. The invention further relates to a method for the production of such salts, a pharmaceutical composition comprising an effective amount of such a salt and such a salt as a medicament and for the treatment and/or prevention of pain.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ENDO OPERATIONS LIMITEDBALLSBRIDGE DUBLIN 4

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Fischer, Andreas Hürtgenwald, DE 276 2875
Lischke, Dagmar Inden-Altdorf, DE 23 45
Peters-Groth, Dagmar Aachen, DE 4 3

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 13, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00